Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

NCT05327803 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
177
Enrollment
INDUSTRY
Sponsor class

Stopped EBO-301 truncated Phase 3 study (n=97) misses primary endpoint; results unable to confirm clinical efficacy observed in Phase 2 study.

Conditions

Interventions

Sponsor

AN2 Therapeutics, Inc